BibTex RIS Kaynak Göster

A Case with Thrombocytopenia Developing after Tirofiban Treatment

Yıl 2010, Cilt: 17 Sayı: 1, 55 - 57, 01.02.2010

Nusret Açıkgöz Necip Ermiş Mehmet Cansel Jülide Yağmur Hasan Pekdemir Ramazan Özdemir

Öz

Platelets have a central role in many cardiovascular events. Tirofiban is a glycoprotein (GP) IIb/IIIa receptor inhibitor that prevents platelet aggregation. In this report, it was aimed to review the thrombocytopenia induced by tirofiban treatment and other causes of thrombocytopenia. Key words: Tirofiban, Thrombocytopenia, GP IIb/IIIa İnhibitors

Anahtar Kelimeler

Tirofiban Thrombocytopenia GP IIb/IIIa İnhibitors

Kaynakça

  • Boersma E, Harrington EA, Moliterno DJ, White H, Simoons ML. Platelet glycoprotein IIb/IIIa inhibitors in acute coronary syndromes: a metaanalysis of all major randomised clinical trials. Lancet 2002;359(9302):189-98.
  • Karvouni E, Katritsis DG, Ioannidis JP. Intravenous glycoprotein IIb/IIIa receptor antagonists reduce mortality after percutaneous coronary interventions. J Am Coll Cardiol 2003;41:26-32.
  • Özmen F, Atalar E, Özer N. Akut koroner sendromda trombositler ve glikoprotein IIb/IIIa inhibitörleri. Türk J Cardiol 2007;10:91-100.
  • Abrams CS, Cines DB. Thrombocytopenia after treatment with platelet glycoprotein IIb/IIIa inhibitors. Curr Hematol Rep 2004;3:143-47.
  • Aster RH. Drug-induced immune thrombocytopenia: an overview of pathogenesis. Semin Hematol 1999;362-66.
  • Holmes MB, Kabbani S, Watkins M, Battle RW, Schneider DJ. Abciximab associated pseudothrombocytopenia. Circulation 2000;101:938–39.
  • Warkentin TE, Aird WC, Rand JH. Platelet-endothelial intereactions: sepsis, HIT and antiphospholipid syndrome. Hematology 2003;497-519.
  • Bougie DW, Wilker PR, Wuitschick ED, Curtis BR, Malik M, Levine S, Lind RN, Pereira J, Aster RH. Acute thrombocytopenia after treatment with tirofiban or eptifibatide Thrombocytopenia after tirofiban is associated with antibodies specific for ligand- occupied GPIIb/IIIa. Blood 2002;100:2071-6.
  • Curtis B, Swyers J, Divgi A, McFarland J, Aster R. Thrombocytopenia after second exposure to abciximab is caused by antibodies that recognize abciximab coated platelets. Blood 2002;99:2054-9.
  • Tirofiban Tedavisi Sonrası Gelişen Trombositopeni Olgusu
  • Eryonucu B, Tuncer M, Erkoc R. Repetitive profound thrombocytopenia after treatment with tirofiban: a case report. Cardiovasc Drugs Therapy 2004;18:503-5.
  • Demirkan B, Guray Y, Guray U, Korkmaz S. Differential diagnosis and management of acute profound thrombocytopenia by tirofiban: a case report. J Thromb Thrombolysis 2006;22:77-8.
  • Beiras-Fernandez A, Kowert A, Jiru P, Weis M, Spannagl M, Reichart B, Schmoeckel M. Acute profound thrombocytopenia after treatment with tirofiban and off-pump coronary artery bypass grafting. Ann Thorac Surg 2009;87(2):629-31.

Tirofiban Tedavisi Sonrası Gelişen Trombositopeni Olgusu

Yıl 2010, Cilt: 17 Sayı: 1, 55 - 57, 01.02.2010

Nusret Açıkgöz Necip Ermiş Mehmet Cansel Jülide Yağmur Hasan Pekdemir Ramazan Özdemir

Öz

Trombositler birçok kardiyovasküler olayda merkezi role sahiptirler. Tirofiban, trombosit agregasyonunu önleyen bir glikoprotein (GP) IIb/IIIa reseptör inhibitörüdür. Bu olguda tirofiban tedavisi sonrası gelişen trombositopeni ve trombositopeni yapan diğer nedenlerin gözden geçirilmesi amaçlandı. Anahtar kelimeler: Tirofiban, Trombositopeni, GP IIb/IIIa İnhibitörleri

Anahtar Kelimeler

Tirofiban Trombositopeni GP IIb/IIIa İnhibitörleri

Kaynakça

  • Boersma E, Harrington EA, Moliterno DJ, White H, Simoons ML. Platelet glycoprotein IIb/IIIa inhibitors in acute coronary syndromes: a metaanalysis of all major randomised clinical trials. Lancet 2002;359(9302):189-98.
  • Karvouni E, Katritsis DG, Ioannidis JP. Intravenous glycoprotein IIb/IIIa receptor antagonists reduce mortality after percutaneous coronary interventions. J Am Coll Cardiol 2003;41:26-32.
  • Özmen F, Atalar E, Özer N. Akut koroner sendromda trombositler ve glikoprotein IIb/IIIa inhibitörleri. Türk J Cardiol 2007;10:91-100.
  • Abrams CS, Cines DB. Thrombocytopenia after treatment with platelet glycoprotein IIb/IIIa inhibitors. Curr Hematol Rep 2004;3:143-47.
  • Aster RH. Drug-induced immune thrombocytopenia: an overview of pathogenesis. Semin Hematol 1999;362-66.
  • Holmes MB, Kabbani S, Watkins M, Battle RW, Schneider DJ. Abciximab associated pseudothrombocytopenia. Circulation 2000;101:938–39.
  • Warkentin TE, Aird WC, Rand JH. Platelet-endothelial intereactions: sepsis, HIT and antiphospholipid syndrome. Hematology 2003;497-519.
  • Bougie DW, Wilker PR, Wuitschick ED, Curtis BR, Malik M, Levine S, Lind RN, Pereira J, Aster RH. Acute thrombocytopenia after treatment with tirofiban or eptifibatide Thrombocytopenia after tirofiban is associated with antibodies specific for ligand- occupied GPIIb/IIIa. Blood 2002;100:2071-6.
  • Curtis B, Swyers J, Divgi A, McFarland J, Aster R. Thrombocytopenia after second exposure to abciximab is caused by antibodies that recognize abciximab coated platelets. Blood 2002;99:2054-9.
  • Tirofiban Tedavisi Sonrası Gelişen Trombositopeni Olgusu
  • Eryonucu B, Tuncer M, Erkoc R. Repetitive profound thrombocytopenia after treatment with tirofiban: a case report. Cardiovasc Drugs Therapy 2004;18:503-5.
  • Demirkan B, Guray Y, Guray U, Korkmaz S. Differential diagnosis and management of acute profound thrombocytopenia by tirofiban: a case report. J Thromb Thrombolysis 2006;22:77-8.
  • Beiras-Fernandez A, Kowert A, Jiru P, Weis M, Spannagl M, Reichart B, Schmoeckel M. Acute profound thrombocytopenia after treatment with tirofiban and off-pump coronary artery bypass grafting. Ann Thorac Surg 2009;87(2):629-31.
Toplam 13 adet kaynakça vardır.

Ayrıntılar

Birincil Dil Türkçe
Bölüm Makaleler
Yazarlar

Nusret Açıkgöz Bu kişi benim

Necip Ermiş Bu kişi benim

Mehmet Cansel Bu kişi benim

Jülide Yağmur Bu kişi benim

Hasan Pekdemir Bu kişi benim

Ramazan Özdemir Bu kişi benim

Yayımlanma Tarihi 1 Şubat 2010
Yayımlandığı Sayı Yıl 2010 Cilt: 17 Sayı: 1

Kaynak Göster

APA Açıkgöz, N., Ermiş, N., Cansel, M., Yağmur, J., vd. (2010). Tirofiban Tedavisi Sonrası Gelişen Trombositopeni Olgusu. Journal of Turgut Ozal Medical Center, 17(1), 55-57.
AMA Açıkgöz N, Ermiş N, Cansel M, Yağmur J, Pekdemir H, Özdemir R. Tirofiban Tedavisi Sonrası Gelişen Trombositopeni Olgusu. Turgut Özal Tıp Merk Derg. Şubat 2010;17(1):55-57.
Chicago Açıkgöz, Nusret, Necip Ermiş, Mehmet Cansel, Jülide Yağmur, Hasan Pekdemir, ve Ramazan Özdemir. “Tirofiban Tedavisi Sonrası Gelişen Trombositopeni Olgusu”. Journal of Turgut Ozal Medical Center 17, sy. 1 (Şubat 2010): 55-57.
EndNote Açıkgöz N, Ermiş N, Cansel M, Yağmur J, Pekdemir H, Özdemir R (01 Şubat 2010) Tirofiban Tedavisi Sonrası Gelişen Trombositopeni Olgusu. Journal of Turgut Ozal Medical Center 17 1 55–57.
IEEE N. Açıkgöz, N. Ermiş, M. Cansel, J. Yağmur, H. Pekdemir, ve R. Özdemir, “Tirofiban Tedavisi Sonrası Gelişen Trombositopeni Olgusu”, Turgut Özal Tıp Merk Derg, c. 17, sy. 1, ss. 55–57, 2010.
ISNAD Açıkgöz, Nusret vd. “Tirofiban Tedavisi Sonrası Gelişen Trombositopeni Olgusu”. Journal of Turgut Ozal Medical Center 17/1 (Şubat 2010), 55-57.
JAMA Açıkgöz N, Ermiş N, Cansel M, Yağmur J, Pekdemir H, Özdemir R. Tirofiban Tedavisi Sonrası Gelişen Trombositopeni Olgusu. Turgut Özal Tıp Merk Derg. 2010;17:55–57.
MLA Açıkgöz, Nusret vd. “Tirofiban Tedavisi Sonrası Gelişen Trombositopeni Olgusu”. Journal of Turgut Ozal Medical Center, c. 17, sy. 1, 2010, ss. 55-57.
Vancouver Açıkgöz N, Ermiş N, Cansel M, Yağmur J, Pekdemir H, Özdemir R. Tirofiban Tedavisi Sonrası Gelişen Trombositopeni Olgusu. Turgut Özal Tıp Merk Derg. 2010;17(1):55-7.